BioCentury | Aug 2, 2019
Company News

Aug. 1 Company Quick Takes: Nektar gains on breakthrough for NKTR-214; plus Adaptive's MRD test, Acadia, Vanda and more

...trials for up to two candidates by 2024. Eton seeks approval of ET-105 for seizures Eton Pharmaceuticals Inc....
...figures provided by FactSet. BioCentury Staff clonoSEQ Assay (Brand), clonoSEQ test (Informal), clonoSEQ Assay (Informal) Acadia Pharmaceuticals Inc. Adaptive Biotechnologies Eton Pharmaceuticals Inc. Evotec...
BioCentury | Jan 12, 2019
Finance

Warning: cash needed

...KOSDAQ:208430) 11/21/18 $42.6 $362.6 $488.8 35% AlzeCure Pharma AB (SSE:ALZCUR) 11/20/18 $22.2 $58.6 $34.6 -41% Eton Pharmaceuticals Inc....
BioCentury | Nov 16, 2018
Financial News

Eton raises $21.6M in IPO

...efficacy from the scientific literature or from previously approved products. Eton Pharmaceuticals Inc. (NASDAQ:ETON), Deer Park, Ill. Chris Lieu Eton Pharmaceuticals Inc....
Items per page:
1 - 3 of 3
BioCentury | Aug 2, 2019
Company News

Aug. 1 Company Quick Takes: Nektar gains on breakthrough for NKTR-214; plus Adaptive's MRD test, Acadia, Vanda and more

...trials for up to two candidates by 2024. Eton seeks approval of ET-105 for seizures Eton Pharmaceuticals Inc....
...figures provided by FactSet. BioCentury Staff clonoSEQ Assay (Brand), clonoSEQ test (Informal), clonoSEQ Assay (Informal) Acadia Pharmaceuticals Inc. Adaptive Biotechnologies Eton Pharmaceuticals Inc. Evotec...
BioCentury | Jan 12, 2019
Finance

Warning: cash needed

...KOSDAQ:208430) 11/21/18 $42.6 $362.6 $488.8 35% AlzeCure Pharma AB (SSE:ALZCUR) 11/20/18 $22.2 $58.6 $34.6 -41% Eton Pharmaceuticals Inc....
BioCentury | Nov 16, 2018
Financial News

Eton raises $21.6M in IPO

...efficacy from the scientific literature or from previously approved products. Eton Pharmaceuticals Inc. (NASDAQ:ETON), Deer Park, Ill. Chris Lieu Eton Pharmaceuticals Inc....
Items per page:
1 - 3 of 3